KalVista Pharmaceuticals, Inc. - Neraca (Quarterly)

KalVista Pharmaceuticals, Inc.
US ˙ NasdaqGM ˙ US4834971032

Talaan ng Balanse (Quarterly)

Neraca KalVista Pharmaceuticals, Inc. menunjukkan saldo akun perusahaan pada titik waktu tertentu. Data Neraca meliputi Aset, Aset Lancar, Aset Tetap, Properti, Pabrik dan Peralatan (PPE), Persediaan, Aset Tak Berwujud, Kewajiban, Kewajiban Lancar, Utang, Kewajiban Sewa Modal, Saham Biasa, Laba Ditahan, Saham Perbendaharaan, dan Ekuitas Pemegang Saham.

Semua angka adalah kelipatan 1,000,000.00 kecuali unit per saham.

2020
10-31
2021
01-31
2021
04-30
2021
07-31
2021
10-31
2022
01-31
2022
04-30
2022
07-31
2022
10-31
2023
01-31
2023
04-30
2023
07-31
2023
10-31
2024
01-31
2024
04-30
2024
07-31
2024
10-31
2025
01-31
2025
04-30
Cash 16 18 51 48 46 46 31 38 39 85 56 49 58 23 32 32 42 167 132
Change (%) 9.60 185.40 -4.45 -3.83 -1.97 -32.57 23.20 1.91 120.42 -33.88 -12.14 16.71 -60.02 37.88 0.19 30.56 302.32 -21.32
Assets Current 72 63 264 250 234 214 194 170 151 192 172 150 129 104 226 192 152 267 242
Change (%) -13.28 322.80 -5.48 -6.13 -8.54 -9.71 -12.00 -11.26 27.06 -10.31 -13.05 -14.17 -19.05 116.79 -15.09 -20.54 75.59 -9.60
Assets 75 66 272 259 244 225 204 182 163 203 183 160 139 114 235 200 161 276 251
Change (%) -12.25 310.86 -4.74 -5.91 -7.69 -9.41 -10.58 -10.69 24.95 -9.96 -12.48 -13.47 -17.86 106.55 -14.96 -19.66 71.60 -9.14
Liabilities 10 8 15 15 16 17 19 18 19 19 22 21 24 25 29 27 27 131 155
Change (%) -27.01 93.95 -0.79 11.12 4.76 9.76 -5.54 7.20 0.01 16.56 -5.32 15.72 4.48 13.54 -4.94 -2.04 387.60 18.73
Equity 65 59 257 244 227 208 185 165 144 184 161 139 114 89 207 173 134 145 95
Change (%) -9.87 339.16 -4.96 -6.94 -8.59 -10.99 -11.09 -12.61 28.25 -12.70 -13.47 -17.86 -22.60 133.21 -16.35 -22.46 8.31 -34.27
Liabilities And Stock Equity 75 66 272 259 244 225 204 182 163 203 183 160 139 114 235 200 161 276 251
Change (%) -12.25 310.86 -4.74 -5.91 -7.69 -9.41 -10.58 -10.69 24.95 -9.96 -12.48 -13.47 -17.86 106.55 -14.96 -19.66 71.60 -9.14

Source: Capital IQ

Other Listings
DE:4XC1 € 13.20
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista